E uiga i le kanesa / togafitiga / togafitiga faʻafomaʻi / faʻamaʻi / gastrointestinal-neuroendocrine-tum-g1 / togafitiga

Togafitiga Togafitiga Togafitiga mo Gastrointestinal Neuroendocrine Tumor G1

Togafitiga faʻafomaʻi o suʻesuʻega suʻesuʻega e aʻafia ai tagata. O faʻataʻitaʻiga ile falemaʻi ile lisi lea mo togafitiga ole gastrointestinal neuroendocrine tumo g1 togafitiga. O faʻataʻitaʻiga uma i luga o le lisi e lagolagoina e le NCI.

O faʻamatalaga taua a le NCI e uiga ile faʻataʻitaʻi ile falemaʻi o loʻo faʻamatalaina ai ituaiga ma vaega o faʻataʻitaʻiga ma faʻafefea ona faʻatinoina. Togafitiga faʻafomaʻi e vaʻai i ni auala fou e puipuia ai, iloa ai, pe togafitia ai faʻamaʻi. Atonu e te manaʻo e mafaufau e uiga i le auai i le faʻataʻitaʻiina o togafitiga. Talanoa i lau fomaʻi mo se fesoasoani i le filifiliga pe o se tasi e talafeagai mo oe.

Faʻataʻitaʻiga 1-4 o le 4

Cabozantinib S-malate i le togafitia o tagata mamaʻi ma Neuroendocrine Tumors na muamua togafitia ma Everolimus O loʻo maua i le lotoifale, Metastatic, pe le mafai ona aveʻesea e taotoga.

O lenei faʻataʻitaʻiga vaega III faʻataʻitaʻiga suʻesuʻe cabozantinib S-malate ia vaʻaia pe o le a le aoga pe a faʻatusatusa i le placebo i le togafitia o tagata mamaʻi ma neuroendocrine tumors muamua na togafitia ma everolimus na salalau atu i autafa o le tino poʻo lymph nodes, na salalau atu i isi nofoaga i le tino, pe le mafai aveese ile taotoga. O le Cabozantinib S-malate o se vailaʻau oona o le chemotherapy e taʻua o le tyrosine kinase inhibitor, ma e faʻatutuina ni tyrosine kinase faʻapitoa mauaina, pe a poloka, e ono faʻatelegeseina le tuputupu aʻe.

Nofoaga: 329 nofoaga

PEN-221 i le Somatostatin Receptor 2 Faʻamatalaina o le maualalo kanesa aofia ai Neuroendocrine ma Laʻitiiti sela sela mama

Maliega PEN-221-001 o se tatala-igoa, multicenter Vaega 1 / 2a suʻesuʻe iloilo PEN-221 i tagata mamaʻi ma SSTR2 faʻaalia alualu i luma gastroenteropancreatic (GEP) poʻo mama po thymus poʻo isi neuroendocrine tumors poʻo laʻititi sela kanesa kanesa po o le tele sela sela neuroendocrine o le māmā.

Nofoaga: 7 nofoaga

Ribociclib ma Everolimus i le togafitia o tagata mamaʻi ma le maualuluga lelei eseese Neuroendocrine Tumors o le amataga amataga

Lenei vaega II suʻesuʻega suʻesuʻe pe faʻafefea ona aoga le ribociclib ma everolimus i le togafitia o tagata mamaʻi ma eseesega eseese neuroendocrine tumors o le foregut amataga na salalau atu i isi vaega o le tino ma masani ona le mafai ona faʻamaloloina pe faʻatonutonuina ma togafitiga. Ribociclib ma everolimus ono taofi le tuputupu aʻe o sela tuma i le polokaina o nisi o enzymes e manaʻomia mo le tuputupu aʻe sela.

Nofoaga: 5 nofoaga

Sapanisertib i le togafitia o tagata mamaʻi ma le Metastatic poʻo le Refractory Pancreatic Neuroendocrine Tumor e le mafai ona aveʻesea e taotoga.

Lenei vaega II suʻesuʻega suʻesuʻe pe o le a le lelei o le sapanisertib galue i le togafitia o tagata mamaʻi ma le pancreatic neuroendocrine tumula ua salalau i isi nofoaga i le tino (metastatic), e le tali atu i togafitiga (refactory), pe le mafai ona aveʻesea se taotoga. O vailaʻau e pei o le sapanisertib e mafai ona taofi ai le tuputupu aʻe pe faʻapipiʻiina sela o le tuma e ala i le poloka o nisi o enzyme e manaʻomia mo le tuputupu aʻe o sela.

Nofoaga: 379 nofoaga